Cspc Pharmaceutical Group Stock Performance
| CSPCY Stock | USD 3.44 0.16 4.88% |
On a scale of 0 to 100, CSPC Pharmaceutical holds a performance score of 7. The firm shows a Beta (market volatility) of 0.3, which signifies not very significant fluctuations relative to the market. As returns on the market increase, CSPC Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding CSPC Pharmaceutical is expected to be smaller as well. Please check CSPC Pharmaceutical's maximum drawdown, as well as the relationship between the skewness and day typical price , to make a quick decision on whether CSPC Pharmaceutical's price patterns will revert.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in CSPC Pharmaceutical Group are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, CSPC Pharmaceutical showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 7.3 B | |
| Total Cashflows From Investing Activities | -637.3 M |
CSPC |
CSPC Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 288.00 in CSPC Pharmaceutical Group on February 4, 2024 and sell it today you would earn a total of 40.00 from holding CSPC Pharmaceutical Group or generate 13.89% return on investment over 90 days. CSPC Pharmaceutical Group is currently producing 0.2387% returns and takes up 2.4214% volatility of returns over 90 trading days. Put another way, 21% of traded pink sheets are less volatile than CSPC, and 96% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
CSPC Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CSPC Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as CSPC Pharmaceutical Group, and traders can use it to determine the average amount a CSPC Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0986
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CSPCY | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.42 actual daily | 21 79% of assets are more volatile |
Expected Return
| 0.24 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average CSPC Pharmaceutical is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CSPC Pharmaceutical by adding it to a well-diversified portfolio.
CSPC Pharmaceutical Fundamentals Growth
CSPC Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of CSPC Pharmaceutical, and CSPC Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CSPC Pink Sheet performance.
| Return On Equity | 0.2 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.22 % | |||
| Current Valuation | 11.19 B | |||
| Shares Outstanding | 2.98 B | |||
| Price To Earning | 15.41 X | |||
| Price To Book | 3.19 X | |||
| Price To Sales | 0.43 X | |||
| Revenue | 27.87 B | |||
| EBITDA | 7.72 B | |||
| Cash And Equivalents | 13.97 B | |||
| Cash Per Share | 4.69 X | |||
| Total Debt | 682.56 M | |||
| Debt To Equity | 0.02 % | |||
| Book Value Per Share | 9.41 X | |||
| Cash Flow From Operations | 4.64 B | |||
| Earnings Per Share | 0.27 X | |||
| Total Asset | 34.74 B | |||
About CSPC Pharmaceutical Performance
To evaluate CSPC Pharmaceutical Pink Sheet as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when CSPC Pharmaceutical generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare CSPC Pink Sheet's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand CSPC Pharmaceutical market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents CSPC's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the Peoples Republic of China, other Asian regions, the Americas, Europe, and internationally. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the Peoples Republic of China. Cspc Pharmaceutical operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 25147 people.Things to note about CSPC Pharmaceutical performance evaluation
Checking the ongoing alerts about CSPC Pharmaceutical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for CSPC Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating CSPC Pharmaceutical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate CSPC Pharmaceutical's pink sheet performance include:- Analyzing CSPC Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CSPC Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining CSPC Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CSPC Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CSPC Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CSPC Pharmaceutical's pink sheet. These opinions can provide insight into CSPC Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CSPC Pharmaceutical Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the CSPC Pharmaceutical information on this page should be used as a complementary analysis to other CSPC Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for CSPC Pink Sheet analysis
When running CSPC Pharmaceutical's price analysis, check to measure CSPC Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CSPC Pharmaceutical is operating at the current time. Most of CSPC Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of CSPC Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CSPC Pharmaceutical's price. Additionally, you may evaluate how the addition of CSPC Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |